Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung CancerTony Mok, Vassiliki A. Papadimitrakopoulou, Hye Ryun Kim et al.|New England Journal of Medicine|2016Cited by 3.3k
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase InhibitorHiroaki Akamatsu, Nobuyuki Yamamoto, Yukihiro Toi et al.|JAMA Oncology|2021Cited by 185